Publication Date
2014
Journal Title
Onco Targets Ther
Abstract
The main concern of long-term use of trastuzumab remains its association with potential cardiac side effects. Although these side effects are real, they are probably overemphasized. We report the case of a woman with metastatic breast cancer, who is currently in complete remission, and who received trastuzumab continuously for more than 9 years, without any significant cardiac toxicity.
Volume Number
7
Pages
1911-1917
Document Type
Article
EPub Date
2014/11/08
Status
Faculty
Facility
School of Medicine
Primary Department
Hematology/Medical Oncology
PMID
DOI
10.2147/ott.s69343